Financings in Brief: MiniMed
This article was originally published in The Gray Sheet
Executive Summary
MiniMed: Infusion system firm nets about $22.2 mil. from secondary offering of 1.5 mil. common stock shares at $26 each. The offering, which included 575,000 shares offered by selling shareholders and 925,000 shares offered by the company, was slightly smaller than originally anticipated: a preliminary prospectus for the offering outlined plans to sell 2 mil. shares ("The Gray Sheet" March 17, p. 11). UBS Securities, Dillon, Read & Co., Hambrecht & Quist and Smith Barney were underwriters...